Physician profile
Christopher Edouard
NPI 1679028856
$1,577.50
in general payments reported to CMS, 2019-2025
16 companies · $669 in 2025
The $669 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.00 · 2022: $39.17 · 2023: $497 · 2024: $296 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $390.15 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $355.50 | 2023-2025 | Austedo Xr, Austedo Xr |
| Abbott Laboratories | $163.11 | 2021-2023 | Freestyle Libre 2 |
| Neurocrine Biosciences, INC. | $127.26 | 2024-2025 | Ingrezza |
| Astrazeneca Pharmaceuticals LP | $103.67 | 2021-2023 | Farxiga |
| Abbvie INC. | $88.32 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $74.32 | 2025 | Cobenfy |
| Exact Sciences Corporation | $58.14 | 2023 | Cologuard Collection Kit |
| Alkermes, INC. | $53.95 | 2025 | Lybalvi, Aristada |
| Otsuka America Pharmaceutical, INC. | $42.00 | 2023-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Seqirus USA INC | $31.67 | 2024 | Flucelvax, Fluad |
| Indivior INC. | $29.20 | 2024 | Perseris |
| Phadia US INC. | $17.45 | 2022 | |
| Lilly USA, LLC | $14.70 | 2024 | Mounjaro, Zepbound |
| Lundbeck LLC | $14.43 | 2025 | Abilify Maintena |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Edouard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.